Conversion of liver allograft recipients from cyclosporine to FK 506-based immunosuppression: benefits and pitfalls

Transplant Proc. 1991 Feb;23(1 Pt 1):14-21.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adult
  • Anti-Bacterial Agents / adverse effects
  • Anti-Bacterial Agents / therapeutic use*
  • Cyclosporins / therapeutic use*
  • Female
  • Follow-Up Studies
  • Graft Rejection
  • Humans
  • Immunosuppressive Agents / therapeutic use*
  • Liver Function Tests
  • Liver Transplantation / immunology*
  • Liver Transplantation / physiology
  • Male
  • Tacrolimus
  • Transplantation, Homologous

Substances

  • Anti-Bacterial Agents
  • Cyclosporins
  • Immunosuppressive Agents
  • Tacrolimus